Cleerly ISCHEMIA vs Merlin.net
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly ISCHEMIA is an AI tool for non-invasive diagnosis of coronary artery ischemia through CCTA scan analysis, aiding in initial treatment planning. In contrast, Merlin.net is a remote monitoring platform for managing patients with implanted cardiac devices, focusing on post-implantation follow-up and device performance. While both operate within cardiology, they address different stages of patient care, with one focused on diagnostic imaging and the other on ongoing device management.
Choose Cleerly ISCHEMIA if…
Choose Cleerly ISCHEMIA if you need an AI-powered, non-invasive tool to assess coronary artery disease and determine the likelihood of ischemia at a vessel level. This is ideal for physicians evaluating patients with suspected CAD via CCTA scans, aiming for personalized diagnosis and treatment planning without immediate invasive procedures.
View Cleerly ISCHEMIA →Choose Merlin.net if…
Choose Merlin.net if you require a robust, web-based platform for the remote monitoring and management of patients with Abbott implanted cardiac devices. This tool is best suited for clinicians needing to track device performance, receive alerts for patient events, and conduct remote follow-ups for ongoing patient care post-implantation.
View Merlin.net →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly ISCHEMIA | Merlin.net |
|---|---|---|
| Deployment | Web-based solution | Web-based |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly ISCHEMIA | Merlin.net |
|---|---|---|
| Name | Cleerly ISCHEMIA | Merlin.net |
| Company | Cleerly | Abbott |
| Description | Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. | Abbott's Merlin.net Patient Care Network (PCN) is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions. |
| Tagline | AI-Powered Precision for Non-Invasive Ischemia Detection | Remote follow-up and patient management for Abbott implanted cardiac devices. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology |
| Key Features | AI-enabled CCTA analysis, Non-invasive fractional flow reserve (FFR) estimation, Vessel-level ischemia likelihood determination, Coronary plaque characterization (volume, type, location), Stenosis severity assessment, 3D digital models of coronary arteries, Comprehensive interactive web-based reports, Integration with PowerScribe via API | Remote monitoring of Abbott implanted cardiac devices, Web-based interface for clinicians, Data management and review of cardiac information, EHRDirectu2122 data transfer for seamless EHR integration (HL7 standards), DirectAlertsu2122 notification for patient events, SmartScheduleu2122 calendar for follow-up coordination, DirectCallu2122 integrated patient communication, DirectTrendu2122 viewer for dynamic device and clinical trends |
Videos
Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Merlin.net.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Cleerly ISCHEMIA is an FDA-cleared AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease. Merlin.net is a web-based remote monitoring platform for clinicians to manage data from patients with implanted cardiac devices, enabling remote follow-up, device performance monitoring, and informed clinical decisions.
Cleerly ISCHEMIA specifically analyzes data from CCTA (Coronary Computed Tomography Angiography) scans to assess coronary arteries for plaque characterization, stenosis severity, and ischemia likelihood. Merlin.net manages and reviews data exclusively from Abbott implanted cardiac devices, such as pacemakers, ICDs, and CRT devices.
Cleerly ISCHEMIA is a web-based platform that transfers data via Cleerly Proxy (VPN or virtual appliance) and offers integration with PowerScribe via API for comprehensive interactive web-based reports. Merlin.net is a cloud-based web application that provides EHRDirectu2122 data transfer for seamless EHR integration using HL7 standards.
Cleerly ISCHEMIA provides AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), and stenosis severity assessment. Merlin.net offers remote monitoring of Abbott implanted cardiac devices, DirectAlertsu2122 notification for patient events, and DirectTrendu2122 viewer for dynamic device and clinical trends.
More Comparisons
More matchups featuring Cleerly ISCHEMIA or Merlin.net
Backers
Who funded each tool's parent company.